- SRPT +1.60%
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
Yahoo Finance · 1 day ago
Open | 132.55 |
High | 133.88 |
Low | 131.16 |
Mkt Cap | 12.54B |
P/E (TTM) | 308.64 |
Div & Yield | N/A & N/A |
Prev. Close | 130.63 |
52 Wk. Low | 55.25 |
52 Wk. High | 159.89 |
Related stocks
Biopharmaceutical company
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 413.46M | 63.10% ▲ |
Net Income | 36.12M | - |
Diluted EPS | 0.37 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.05 | - |
Q1 2024 | -$0.07 | $0.37 |
Q4 2023 | $0.01 | $0.47 |
S&P 500^GSPC | 5,118.48+54.28 (+1.07%) |
Dow 30^DJI | 38,643.72+418.06 (+1.09%) |
Nasdaq^IXIC | 16,135.46+294.50 (+1.86%) |
Apple Inc.AAPL | 184.79+6.80% |
Amgen Inc.AMGN | 316.14+13.57% |
74.04-16.78% |